Tango Therapeutics Inc
TNGX
Get informed when a big investor buys or sells
+ FollowMarket Cap$3.8B
Close$
$-14.59
165.4% downside
Current Fair Value
165.4% downsideOvervalued by 165.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $3.80 Billion |
|---|---|
| Enterprise Value | $3.49 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.87 |
| Beta | 1.15 |
| Outstanding Shares | 149,875,939 |
Return
| Return on Equity | -12.08% |
|---|---|
| Return on Assets | -11.52% |
| Return on Invested Capital | -12.39% |
Valuation & Multiples
| P/E Ratio | -27.46 |
|---|---|
| PEG | -64.71 |
| Price to Sales | - |
| Price to Book Ratio | 3.72 |
| Enterprise Value to Revenue | 64.79 |
| Enterprise Value to EBIT | -26.7 |
| Enterprise Value to Net Income | -29 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.03 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 11, 2026
EPS Estimate
$-0.32
Average shareholder expectationRevenue Estimate
$1.56 M
Average shareholder expectationNext Earnings Call
Expected Date
November 3, 2026
EPS Estimate
$-0.34
Average shareholder expectationRevenue Estimate
$3.28 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.4747▼ 51.19% |
|---|---|
| Total Calls | 444,100▲ 395.65% |
| Total Puts | 210,800▲ 138.46% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 151.93%▲ 26.38% |
|---|---|
| Total Invested | $6.74B▲ 78.63% |
| Investors Holding | 257▲ 59.00% |
ESG Score
No data
About Tango Therapeutics Inc
4 employees